Who
Christine Berni Silverstein
Director
Company insider
Files Form 4 as: Chief Financial Officer, Abeona Therapeutics; Director, Marinus Pharmaceuticals.
In numbers
- Trades disclosed
- 46
- Buys
- 0
- Sells
- 5
- Bought
- $0
- Sold
- $630K
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 7 Jan 2019
- Last trade
- 15 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Jun 2026filed 15 Jun 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $104K18,160 at $5.71 | filing |
| 15 Jun 2026filed 15 Jun 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $104K18,160 at $5.71 | filing |
| 2 Feb 2026filed 4 Feb 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $102K20,070 at $5.09 | filing |
| 2 Feb 2026filed 4 Feb 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $102K20,070 at $5.09 | filing |
| 26 Jan 2026filed 27 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —37,313 at $0.00 | filing |
| 26 Jan 2026filed 27 Jan 2026 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —37,313 at $0.00 | filing |
| 9 Jul 2025filed 10 Jul 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $77K13,093 at $5.86 | filing |
| 11 Feb 2025filed 11 Feb 2025 | Marinus Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —10,450 at $0.00 | filing |
| 11 Feb 2025filed 11 Feb 2025 | Marinus Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —20,900 at $0.00 | filing |
| 11 Feb 2025filed 11 Feb 2025 | Marinus Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —32,400 at $0.00 | filing |
| 11 Feb 2025filed 11 Feb 2025 | Marinus Pharmaceuticals | SEC FORM 4 Code D | $2,5864,702 at $0.55 | filing |
| 7 Feb 2025filed 11 Feb 2025 | Marinus Pharmaceuticals | SEC FORM 4 Code D | $5,1699,398 at $0.55 | filing |
| 31 Jan 2025filed 3 Feb 2025 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —36,101 at $0.00 | filing |
| 26 Aug 2024filed 27 Aug 2024 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —11,797 at $0.00 | filing |
| 8 Jul 2024filed 9 Jul 2024 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Code A | —23,611 at $0.00 | filing |
| 18 Jun 2024filed 20 Jun 2024 | Marinus Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —10,450 at $0.00 | filing |
| 18 Jun 2024filed 20 Jun 2024 | Marinus Pharmaceuticals | SEC FORM 4 Code A | —2,300 at $0.00 | filing |
| 18 Jun 2024filed 20 Jun 2024 | ABEO Abeona TherapeuticsBiotechnology | SEC FORM 4 Sold | $116K25,821 at $4.51 | filing |
| 18 Jan 2024filed 19 Jan 2024 | Marinus Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —20,900 at $0.00 | filing |
| 18 Jan 2024filed 19 Jan 2024 | Marinus Pharmaceuticals | SEC FORM 4 Code A | —4,600 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.